I think we have a right to be testy. The CC bombed and after working hard to get to .70, the share price tanked and continues to tank. But that's nothing new. That's the pattern of all these small biotechs. Go big or go home. Since the CC didn't go big, we have to go home and wait for momentum to start up all over again.

I've conducted my share of meetings and calls. I messed up a lot of them, too, until I learned to consider the constituency. Who am I talking to; what are their needs, what is most important to them; what sticky situations will I need to address, even if I'm not comfortable addressing them. They don't call them stakeholders for nothing. Furthermore, there is nothing wrong with saying, "I don't know and I'll get back to you later"; and then doing it.